Alexandria's Q2 AFFO Beats Estimates, Occupancy Declines

Core Insights - Alexandria Real Estate Equities, Inc. (ARE) reported second-quarter 2025 adjusted funds from operations (AFFO) per share of $2.33, exceeding the Zacks Consensus Estimate of $2.29 but down from $2.36 in the prior year [1][11] - Total revenues reached $762 million, surpassing the consensus estimate of $750.7 million, although this figure showed a slight year-over-year decline [2] - The company experienced healthy leasing activity with a total of 769,815 rentable square feet (RSF) leased during the quarter, indicating strong demand for its office/laboratory space [3] Financial Performance - The rental rate growth was recorded at 5.5% for the quarter, with a cash basis increase of 6.1% [4] - Occupancy rates for operating properties in North America stood at 90.8% as of June 30, 2025, reflecting a decrease of 0.9% from the previous quarter and 3.8% from the same quarter last year [4] - Same-property net operating income (NOI) decreased by 5.4% year-over-year, although it improved by 2% on a cash basis [5][11] Leasing and Tenant Information - Lease renewals and re-leasing accounted for 483,409 RSF, while development and redevelopment leasing totaled 131,768 RSF [3] - Investment-grade or publicly traded large-cap tenants represented 53% of annual rental revenues, with a weighted average remaining lease term of 7.4 years [6] Development and Dispositions - As of June 30, 2025, the company had $785.4 million in completed and pending dispositions and sales of partial interests [7] - During the second quarter, ARE initiated development and redevelopment projects totaling 217,774 RSF, achieving 90% occupancy and generating an incremental annual NOI of $15 million [7] Interest Expenses and Liquidity - Interest expenses increased by 20.8% year-over-year to $55.3 million [7][11] - The company ended the second quarter with cash and cash equivalents of $520.5 million, up from $476.4 million at the end of the first quarter, and had a total liquidity of $4.6 billion [9] Notable Events - In July, ARE secured its largest life science lease in history, a 16-year expansion lease for over 466,598 RSF with a multinational pharmaceutical tenant [8]